tion, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider" (Sabaté, 2003, p. 18 ). Nonadherence to medication or dietary regimens causes more than one third of hospital admissions in patients with heart failure (Bosworth, Oddone, & Weinberger, 2006) . One study found that individuals with heart failure who were adherent to medications had a $8,881 reduction in annual medical spending (Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011) .
Despite substantial research focused on improving medication adherence, nonadherence remains a significant problem (Sabaté, 2003) . Interventions can increase medication adherence but there is still a need for additional research to improve intervention effectiveness (Conn et al., 2009; Sabaté, 2003) .
Heart failure is common in older adults (Alagiakrishnan, Banach, Jones, Ahmed, & Aronow, 2013) , and those with heart failure are prescribed complex medication regimens, making adherence particularly challenging in this population (Griffiths, Johnson, Piper, & Langdon, 2004) . The World Health Organization proposes five factors affect medication adherence: patientrelated barriers, therapy-related barriers, condition-related barriers, social/economic factors, and health system barriers (Sabaté, 2003) . Heart failure leads to debilitating symptoms, and medications, such as diuretics, have significant side effects that cause this population to face different challenges to adherence than others (Heart Failure Society of America, 2010) . Patients with heart failure believe medications decrease symptoms and may stop taking their medications if they do not lesson symptoms (Granger, 2004) . Additional barriers to medication adherence that older adults face, making them different than other age groups, include cognitive level, forgetfulness, and complexity of medication regimens (Gellad, Grenard, & Marcum, 2011; Siabani, Leeder, & Davidson, 2013) . It is crucial to consider these factors when formulating interventions to improve adherence.
The purpose of the current review was to summarize interventions designed to improve medication adherence in older adults with heart failure. To the current authors' knowledge, no report has systematically reviewed interventions to improve medication adherence in this population. The review included intervention studies with only older adult populations, making it different from previous reviews (Molloy, O'Carroll, Witham, & McMurdo, 2012) . Older adults have different challenges to adherence, such as complex medication regimens, possible financial issues due to retirement, and possible need for help with medication taking, making it crucial to study this population separately (Yap, Thirumoorthy, & Kwan, 2016) . By identifying promising interventions, knowledge can guide future research and practice. Improving medication adherence in the growing older adult population can have a significant impact on health (Sabaté, 2003) .
METHOD
A systematic review method was used following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to summarize the results of multiple studies exploring the effectiveness of interventions to improve medication adherence in older adults with heart failure. PRISMA guidelines comprise a 27-item checklist and flow diagram depicting records identified and included and excluded studies. The guidelines were established to improve transparency and clarity of systematic reviews and meta-analyses (Moher, Liberati, Tetzlaff, & Altman, 2009 ).
Search Strategies
A comprehensive search was completed with assistance from a health sciences research librarian. Databases searched included PubMed (1940 PubMed ( -2015 , CINAHL (1982 CINAHL ( -2015 , PsycINFO (1806 PsycINFO ( -2015 , and Embase . There was no date restriction; articles from the database foundation date to July 2015 were included. Reference lists were also searched to identify additional studies. Keywords included: adherence, compliance, persistence, concordance, nonadherence, non-adherence, noncompliance, non-compliance, heart failure, cardiac failure, heart decompensation, myocardial failure, cardiomyopath*, pharmaceutic*, prescript*, medicat*, medicine, medicines, drugs, intervention*, random*, control*, clinical*, and trial*.
Eligibility Criteria
Only higher-level evidence designs of randomized controlled trials (RCTs) or quasi-experimental designs were included. Inclusion criteria were: intervention study, medication adherence measured as the primary or secondary outcome, inclusion criteria of diagnosis of heart failure, and participants 45 or older. Previous research of older adults with heart failure used a wide range of age criteria to define older adults. Some studies defined older adults as 60 or older (Alagiakrishnan et al., 2013) , whereas others defined them as ages 45 to 50 or older (Dickson et al., 2014; Goldstein et al., 2014; Hope, Wu, Tu, Young, & Murray, 2004; Morrow et al., 2005) . Because age at diagnosis of heart failure is decreasing (Go et al., 2014) , age 45 or older was selected for the current systematic review for the findings to be more generalizable.
Studies were excluded if they were not published in English or were dissertations or unpublished manuscripts.
Trial Selection
The initial search yielded 5,204 articles. After duplicates were removed, 4,275 articles remained. Articles were then screened by title and removed if the title included a different disease than heart failure; was a systematic review, literature review, or meta-analysis; or focused on other adherence behaviors. This screening resulted in 337 articles remaining to be screened for eligibility. Eight studies met criteria for inclusion. The trial selection PRISMA chart is shown in the Figure. 
Data Extraction
Data were extracted from the eight selected studies by the first author (A.M.A.) and verified by a coauthor (C.L.R. 
Quality Assessment
Study quality was assessed using the Downs and Black (1998) scoring tool, which was formulated for use in epidemiology studies but is useful for health science research. The tool comprises 27 items that consider reporting, external and internal validity, selection bias, and sample power. This tool was found to have high internal consistency (KuderRichardson test = 0.89), good criterion validity, and good test-retest (0.88) and interrater reliability (0.75) (Downs & Black, 1998) . Quality scoring was completed by two authors (A.M.A., C.L.R.) and compared for differences. Differences were resolved by discussion and resulted in no unresolved quality scoring disagreements. Results of quality scoring are shown in Table 2 .
RESULTS
Of eight included studies, four were RCTs (Fulmer et al., 1999; Goodyer, Miskelly, & Milligan, 1995; Murray et al., 2007; Rich, Gray, Beckham, Wittenberg, & Luther, 1996) , three were pilot RCTs (Barnason, Zimmerman, Hertzog, & Schulz, 2010; Barnason et al., 2003; Varma, McElnay, Hughes, Passmore, & Varma, 1999) , and one used a quasi-experimental design without a control group (Goldstein et al., 2014) . Quality scores ranged from 10 to 26, with an average score of 17. Quality scoring results are listed in Table 2 . Study publication years ranged from 1995-2014 and sample sizes ranged from 35 (Barnason et al., 2003) to 314 (Murray et al., 2007) participants. Mean age of participants ranged from 62 (Murray et al., 2007) to 84.5 (Goodyer et al., 1995) . Only one study attempted to include only nonadherent patients (Barnason et al., 2010) . The studies were conducted in the United States (n = 6) (Barnason et al., 2010; Barnason et al., 2003; Fulmer et al., 1999; Goldstein et al., 2014; Murray et al., 2007; Rich et al., 1996) , Northern Ireland (n = 1) (Varma et al., 1999) , and the United Kingdom (n = 1) (Goodyer et al., 1995) .
Interventionists included pharmacists (Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) , RNs (Barnason et al., 2010; Barnason et al., 2003; Rich et al., 1996) , research assistants (Fulmer et al., 1999; Goldstein et al., 2014) , and dietitians and social workers (Rich et al., 1996) . Intervention duration ranged from 2 weeks (Barnason et al., 2010) to 12 months (Varma et al., 1999) . Participants were contacted one time (Goldstein et al., 2014; Varma et al., 1999) , twice (Barnason et al., 2010; Rich et al., 1996) , daily for 6 weeks (Barnason et al., 2003; Fulmer et al., 1999) , every 2 weeks for 3 months (Goodyer et al., 1995) , and every 2 months for 1 year (Murray et al., 2007) .
Only two studies used a theorydriven intervention (i.e., Bandura's [2004] social cognitive theory) (Barnason et al., 2010; Barnason et al., 2003) , in which interacting influences shaped new behaviors including personal factors and the physical and social environment. An assumption of this theory is that behaviors occur if an individual has the attitude and ability to perform a behavior and has outcome expectations (Bandura, 2004) . Only one of these two studies had a statistically significant improvement in medication adherence (Barnason et al., 2010) . Study intervention types included educational, affective, and behavioral. Education was used in six studies (Barnason et al., 2010; Barnason et al., 2003; Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) . No interventions used education alone. Counseling, which is an affective intervention, was used in two studies (Barnason et al., 2010; Goodyer et al., 1995) . Behavioral interventions were used in seven studies and included: decreasing dose regimens, telephone follow up, diary cards, and using an icon on the medication bottle that was also on the medication information sheet phone reminder, phone application recording of medication taking, pillboxes with reminders, and intervention device (Barnason et al., 2003; Fulmer et al., 1999; Goldstein et al., 2014; Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) . Two studies used only one type of intervention (Fulmer et al., 1999; Goldstein et al., 2014) , five studies used two types of interventions (Barnason et al., 2010; Barnason et al., 2003; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) , and one study used all three types of interventions (Goodyer et al., 1995) .
Medication adherence can be measured using objective (e.g., pill counts, electronic measuring devices, refill reports, supervised dosing, blood drug levels) or subjective (e.g., self-report, provider assessments) measures (Bosworth et al., 2006; O'Donohue & Levensky, 2006) . Four studies used objective measures (Fulmer et al., 1999; Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996) and two used subjective measures (Barnason et al., 2010; Barnason et al., 2003) . Two studies used a combination of subjective and objective measures (Goldstein et al., 2014; Varma et al., 1999) . Goldstein et al. (2014) used objective measures in one group and subjective mea- sures in another group. Four studies measured adherence immediately after the intervention (Goldstein et al., 2014; Goodyer et al., 1995; Rich et al., 1996; Varma et al., 1999) , one measured adherence 2 weeks postintervention (Fulmer et al., 1999) , and three measured adherence 3 months post-intervention (Barnason et al., 2010; Barnason et al., 2003; Murray et al., 2007) .
Five studies (63%) documented a statistically significant improvement in medication adherence rates in the intervention group (Barnason et al., 2010; Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) . One study did not have a control group but had two intervention groups comparing two different reminder devices; there was no significant difference in adherence rates between devices (Goldstein et al., 2014) . Two studies showed no significant difference in medication adherence rates (Barnason et al., 2003; Fulmer et al., 1999) . These three studies used technology in the intervention.
DISCUSSION
The purpose of the current article was to systematically review RCTs and quasi-experimental intervention studies designed to improve medication adherence in older adults with heart failure. Five of eight studies (63%) found a statistically significant improvement in medication adherence in intervention groups. All five studies used a combination of educational, behavioral, and affective interventions. These findings are consistent with previous research that suggests combined interventions have a greater impact on improving adherence (Conn et al., 2009; Roter et al., 1998; van Dalem, Krass, & Aslani, 2012) . Conn et al. (2009) found that behavioral interventions, including dosing simplification and reminder cues, had large adherence effect sizes in older adults. In the current review, dosing simplification was used in two studies and reminder cues in two studies, with statistically significant improvement in medication adherence.
Pharmacists performed the intervention in four studies, showing significant improvement in medication adherence (Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) . A previous systematic review on interventions to improve medication adherence in the heart failure population also found the use of pharmacists as interventionists to be beneficial (Molloy et al., 2012) . Two studies that did not show a statistically significant improvement in medication adherence used technology interventions, including a telephone device and smartphone application (Barnason et al., 2003; Goldstein et al., 2014) . Use of technology can be challenging in the older adult population due to physical changes and decreased use (Fletcher & Jensen, 2015) . It is crucial to adapt technological interventions to meet the needs of older adults to be successful (Haugh, 2014) . It was unclear in the two studies whether adaptations were made specific to older adults.
Quality scoring of the studies using the Downs and Black (1998) tool revealed that the studies are of average quality. All of the studies took place in clinics or hospitals, which is the typical setting in which patients with heart failure receive care. Use of results is impacted due to small samples, lack of generalizability, and average quality scoring. A prior systematic review on medication adherence interventions in patients with heart failure also concluded there was a lack of high-quality evidence (Molloy et al., 2012) .
Only two studies used theory, emphasizing the need for more theory-driven intervention studies (Banning, 2009; Conn et al., 2009; Ruppar, 2010; Russell, Conn, & Jantarakupt, 2006) . Of these two studies, one had a statistically significant improvement in medication adherence. This intervention comprised education and counseling that focused on the concepts of selfcare and self-regulation (Barnason et al., 2010) . The intervention in the study that did not show a significant improvement in adherence comprised a telephone device that focused on positive reinforcement to improve self-efficacy (Barnason et al., 2003) .
The longest follow up of medication adherence was 3 months in three studies (Barnason et al., 2010; Barnason et al., 2003; Murray et al., 2007) . Heart failure is a progressive disease in which medications must be taken indefinitely. As the disease progresses, symptoms worsen, which can make medication adherence a further challenge (Heart Failure Society of America, 2010; Sabaté, 2003) , supporting the need for research on the long-term effect of interventions on medication adherence (Haynes, Ackloo, Sahota, McDonald, & Yao, 2008; Molloy et al., 2012) .
Use of technology can be challenging in the older adult population due to physical changes and decreased use.
Four studies that significantly improved medication adherence used interventions that focused solely on medication adherence (Barnason et al., 2010; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999) . A recent meta-analysis found that focusing on only one health behavior at a time has larger effect sizes than focusing on multiple health behaviors (Ruppar, Delgado, & Temple, 2015) . A change is more likely to occur when focusing on one behavior because it is easier for the individual to achieve.
STRENGTHS AND LIMITATIONS
Various strengths are noted in the intervention studies. The first strength is that seven of eight studies (87.5%) used a RCT design, which is considered the gold standard for determining cause and effect and produces a high level of evidence (Polit, 2008) . An additional strength is that six studies (83.3%) used objective measures of medication adherence, such as pill counts and electronic monitoring devices. Objective measures are seen as gold standard because subjective measures tend to overreport adherence (O'Donohue & Levensky, 2006) . Other study strengths were noted during quality assessment. All studies had a clear aim, outcome, and inclusion criteria. The settings selected and interventionists used were representative of the general settings in which treatment is normally received. The interventions were also performed so that internal validity was maintained.
Limitations were noted in the current systematic review and reviewed studies. Despite using a systematic search process, some studies may have been missed. To minimize the chance of missing articles, a health sciences research librarian was used in the search.
Limitations of the reviewed studies include no measurement of long-term effects, small samples that limited power, and four of eight studies were published in the 1990s.
There is a need for research studying long-term effects of interventions, which was not satisfied by the longest follow up of 3 months. Three studies were pilot studies, which explains the small samples. However, only one study used a power analysis to determine sample size, increasing the risk of a type II error or accepting a false null hypothesis (Polit, 2008) . No publication date restriction was used as inclusion criteria so that adequate study numbers could be included. One disadvantage of studies published more than 10 years ago is that technology has advanced, making the interventions (e.g., using home telephones for reminders) out of date.
To prevent the "ceiling" effect, it is best to include only nonadherent patients in studies. Only one study attempted to include nonadherent patients (Barnason et al., 2010) . Adherence was not screened prior to the start of the study but only participants at risk for low medication adherence (taking five or more medications) were included, which is not a good measure of nonadherence.
Quality of the articles was average. Weaknesses noted in most studies regarded external validity, meaning the study results may not be generalizable to the larger population (Polit, 2008) . There were also weaknesses noted in the selection of participants in most of the studies.
IMPLICATIONS
Current findings suggest guidance for future research studies. Medication adherence is challenging, particularly in older adults with heart failure. The populations of patients with heart failure and older adults with heart failure possess different challenges to adherence, so studying the populations together is needed. Few studies exist using this combined population, making it difficult to make practice changes. Studies that use objective measures, larger samples, include solely nonadherent patients, and study long-term effects can enhance medication adherence knowledge.
Only two studies reviewed used theories as a framework. Based on previous research, there is a need for additional interventions using theory (Ruppar, 2010) . The social cognitive theory was used in these two studies. This theory tends to focus more on the individual. A significant amount of research exists on improving medication adherence focusing on behavior changes at the individual level; however, there has not been an improvement in medication adherence (Haynes et al., 2008; Kripalani, Yao, & Haynes, 2007; Russell et al., 2006) . There is a need for interventions that focus on multilevel influences and consider environmental factors (Berben et al., 2015; Russell, Ruppar, & Matteson, 2011) . Linking medication taking to existing habits has been found to improve medication adherence (Conn, Ruppar, Enriquez, & Cooper, 2016) .
Improving adherence to medications that decrease symptoms and ultimately mortality should be a focus of all health care providers. The current findings can help health care providers identify useful interventions to improve medication adherence in older adults with heart failure and use them in practice. Adherence should be assessed and interventions using a combination of approaches should be implemented. Medication regimens should be simplified if clinically possible. An interdisciplinary approach including pharmacists should be followed. Changes in behavior should focus on one behavior at a time. A plan to use reminder cues should also be initiated. Although education alone does not improve adherence, it is an important component of combined interventions. Nurses can provide health teaching and information about intended effects of therapies, such as medications, which is part of the American Nurses Association's (2010) standards of professional nursing practice.
CONCLUSION
Eight studies that trialed interventions to improve medication adherence in older adults with heart failure were reviewed. The five studies that showed significant improvement in medication adherence used combined intervention approaches. By reviewing strengths and limitations of these studies and comparing to the literature, guidance for future studies can be established. There is a need for interventions that use theory and intervention components found to be previously effective. Study designs can be improved by considering external validity, having larger samples, measuring long-term effects, and including only nonadherent patients.
Medication nonadherence in heart failure leads to poor patient outcomes, including symptom exacerbation, hospital admissions, and death (van der Wal & Jaarsma, 2008) . Medication adherence is so crucial that the World Health Organization posed that improving medication adherence can have a greater effect on health than formulating new medical treatments (Sabaté, 2003) . Formulating new interventions to improve medication adherence in older adults with heart failure and testing their effectiveness in high-quality research should be a priority.
